Clearside Biomedical (CLSD) Misses Q1 EPS by 3c

Clearside Biomedical (NASDAQ: CLSD) reported Q1 EPS of ($0.17), $0.03 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $230 thousand versus the consensus estimate of $570.83 thousand.

For earnings history and earnings-related data on Clearside Biomedical (CLSD) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• The LGL Group (LGL) Misses Q2 EPS by 8c